Myocardial damage due to ischemia and reperfusion in hypertriglyceridemic and hypertensive rats: Participation of free radicals and calcium overload

Journal of Hypertension

Volumn 17, Issue 11, 1999, Pages 1607-1616

  Carvajal, Karla ^a   El Hafidi, Mohammed ^a   Baños, Guadalupe ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Hypertension; Ischemia and reperfusion damage; Ketorolac protection; Metabolic disorders; PEN protection; Risk factors; Sugar induced hypertriglyceridemia

Indexed keywords

CALCIUM ION; CREATINE KINASE; FREE RADICAL; KETOROLAC; LACTATE DEHYDROGENASE; N TERT BUTYL ALPHA PHENYLNITRONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; HEART ARRHYTHMIA; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID OXIDATION; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SINUS RHYTHM; STRESS;

EID: 0032729524     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917110-00015     Document Type: Article

References (40)

1. Krzesinski JM, Carlier PG, Rorive GL. Interrelationship of hypertension, plasma lipids and atherosclerosis. Drugs 1988; 36 (suppl 2):18-26.
2. Reaven GM. Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models. Diabetes Care 1991; 14:195-203.
3. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987; 10:512-516.
4. Reaven GM, Ho H. Sugar-induced hypertension in Sprague-Dawley rats. Am J Hypertens 1991; 4:610-614.
5. Bānos G, Carvajal K, Cardoso G, Zamora J, Franco M. Vascular reactivity and effect of serum in a rat model of hypertriglyceridemia and hypertension. Am J Hypertens 1997; 10:379-388.
6. El Hafidi M, Bānos G. In vivo plasma lipid oxidation in sugar-induced rat hypertriglyceridemia and hypertension. Hypertension 1997; 30:624-628.
7. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation 1989; 80:1049-1062.
8. Hess ML, Manson NH, Okabe E. Involvement of free radicals in the pathophysiology of ischemic heart disease. Can J Physiol Pharmacol 1982; 60:1382-1389.
9. Nägele U, Hägele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, et al. Reagent for the enzymatic determination of serum triglycerides with improved lipolytic efficiency. J Clin Chem Biochem 1984; 22:165-174.
10. Siedel J, Hagele DE, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of total cholesterol with improved lipolytic efficiency. Clin Chem 1983; 29:1075-1080.
11. Selye H, Bajusz E, Grasso S, Mendell P. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 1960; 11:398-407.
12. Girotti AW. Mechanism of lipid peroxidation. J Free Radic Biol Med 1985; 1:87-95.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 14:425-449.
14. Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ, Yellon DM, et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 1988; 7:447-455.
15. Chávez R, Bravo C, Zazueta C, Pichardo J, Uribe A, Corona N, et al. Ionophoretic-like properties of ketorolac for calcium. J Pharm Exp Ther 1993; 267:1134-1139.
16. Chávez E, Téllez F, Pichardo J, Milàn R, Cuéllaán R, Cuèllar A, et al. On the protection by ketorolac of reperfusion-induced heart damage. Comp Biochem Physiol 1996; 115C:95-100.
17. Lee YM, Peng YY, Ding YA, Yen M. Losartan attenuates myocardial ischemia-induced ventricular arrhythmias and reperfusion. Am J Hypertens 1997; 10:852-858.
18. Hearse DJ, Tosaki A. Free radicals and reperfusion-induced arrhythmias: protection by spin-trap agent PBN in the rat heart Circ Res 1987; 60:375-383.
19. Bradamante S, Monti E, Paracchini L, Lazzarini E, Piccinini F. Protective activity of the spin trap tert-butyl-alpha-phenyl nitrone (PBN) in reperfused rat heart. J Mol Cell Cardiol 1992; 24:375-386.
20. Heuer HJ, Bernauer W. Myocardial damage by ventricular fibrillation in isolated perfused rat hearts, and its underlying mechanism. Basic Res Cardiol 1986; 81:188-198.
21. Hearse DJ. Reperfusion of the ischemic myocardium. J Mol Cell Cardiol 1977; 9:605-616.
22. Nayler WG. The role of calcium in the ischemic myocardium. Am J Pathol 1981; 102:262-270.
23. Opie LH, Coetzee WA. Role of calcium ions in reperfusion arrhythmias: relevance to pharmacological intervention. Cardiovasc Drugs Ther 1989; 2:623-633.
24. Bolli R, Jeroudi MO, Patel DS, DuBose CM, Lai EK, Roberts R, et al. Direct evidence that oxygen-derived free radicals contribute to post-ischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci 1989; 86:4695-5004.
25. Manning AS, Singal PK, Hearse DJ. Reperfusion-induced arrhythmias in the rat: mechanisms and prevention. J Mol Cell Cardiol 1984; 16:497-518.
26. Bolli R, Jeroudi MO, Patel BS, Arouma OI, Halliwell B, Lai EK, et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion - evidence that myocardial stunning is a manifestation of reperfusion injury. Circ Res 1989; 65:607-622.
27. Zicha J, Kunes J, David-Dufilho M, Pernollet MG, Devynck MA. Cell calcium handling and intracellular pH regulation: reduced platelet response to thrombin stimulation Life Sci 1996; 59:803-813.
28. Shen A, Jennings RB. Myocardial calcium and magnesium in acute ischemic injury. Am J Pathol 1972; 67:417-440.
29. Griffiths EJ, Brunt RV. The effect of calcium antagonists on the activities of lipid metabolizing enzymes in the isolated ischaemically perfused and reperfused rat heart. J Mol Cell Cardiol 1990; 22:303-310.
30. Nayler WG, Liu JJ, Panagiotopoulos S. Nifedipine and experimental cardioprotection. Cardiovasc Drugs Ther 1990; 4 (suppl 5):879-885.
31. Higgins AJ, Blackburn KJ. Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonists. J Mol Cell Cardiol 1984; 16:427-438.
32. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Frec Radic Biol Med 1990; 9:515-540.
33. Kirshenbaum LA, Singal PK. Increase in endogenous antioxidant enzymes protects hearts against reperfusion injury Am J Physiol 1993; 265:H484-H493.
34. Parodies G, Ruggiero FM, Petrosillo G, Quagliariello E. Peroxidative damage to cardiac mitochondria: cytochrome oxidase and cardiolipin alterations. FEDS Lett 1998; 424:155-158.
35. Liedtke AJ, DeMaison L, Eggleston AM, Cohen LM, Nelis SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res 1988; 62:535-542.
36. Verwaerde P, Galinier M, Rougé P, Massabuau P, Galitzky J, Sènard JM, et al. Hypertension artérielle expérimentale induite par un régime hypercalorique. Arch Mal Coeur Vaiss 1996; 89:1019-1023.
37. Kumar KV, Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 1993; 19:59-66.
38. Swei A, Lacy F, DeLano FA, Schmid Schönbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension 1997; 30:1628-1633.
39. Ito H, Torii M, Suzuki T. Comparative study on free radical injury in the endothelium of SHR and WKY aorta. Clin Exp Pharmacol Physiol 1995; 1 (suppl):S157-S159.
40. Hayoz D, Weber R, Sutschmann B, Darioli R, Burnier M, Waeber B, et al. Postischemic blood flow response in hypercholesterolemic patients. Hypertension 1995; 26:497-502.